|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sung JJ, Ng SC, Chan FK, Chiu HM, Kim HS,
Matsuda T, Ng SS, Lau JY, Zheng S, Adler S, et al; Asia Pacific
Working Group. An updated Asia Pacific Consensus Recommendations on
colorectal cancer screening. Gut. 64:121–132. 2015. View Article : Google Scholar
|
|
3
|
Center MM, Jemal A, Smith RA and Ward E:
Worldwide variations in colorectal cancer. CA Cancer J Clin.
59:366–378. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Stein U and Schlag PM: Clinical,
biological, and molecular aspects of metastasis in colorectal
cancer. Recent Results Cancer Res. 176:61–80. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Simon-Chazottes D, Matsubara S, Miyauchi
T, Muramatsu T and Guénet JL: Chromosomal localization of two cell
surface-associated molecules of potential importance in
development: Midkine (Mdk) and basigin (Bsg). Mamm Genome.
2:269–271. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kasinrerk W, Fiebiger E, Stefanová I,
Baumruker T, Knapp W and Stockinger H: Human leukocyte activation
antigen M6, a member of the Ig superfamily, is the species
homologue of rat OX-47, mouse basigin, and chicken HT7 molecule. J
Immunol. 149:847–854. 1992.PubMed/NCBI
|
|
7
|
Saxena DK, Oh-Oka T, Kadomatsu K,
Muramatsu T and Toshimori K: Behaviour of a sperm surface
transmembrane glycoprotein basigin during epididymal maturation and
its role in fertilization in mice. Reproduction. 123:435–444. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rosenthal EL, Shreenivas S, Peters GE,
Grizzle WE, Desmond R and Gladson CL: Expression of extracellular
matrix metalloprotease inducer in laryngeal squamous cell
carcinoma. Laryngoscope. 113:1406–1410. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gallagher SM, Castorino JJ, Wang D and
Philp NJ: Monocarboxylate transporter 4 regulates maturation and
trafficking of CD147 to the plasma membrane in the metastatic
breast cancer cell line MDA-MB-231. Cancer Res. 67:4182–4189. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pan Y, He B, Song G, Bao Q, Tang Z, Tian F
and Wang S: CD147 silencing via RNA interference reduces tumor cell
invasion, metastasis and increases chemosensitivity in pancreatic
cancer cells. Oncol Rep. 27:2003–2009. 2012.PubMed/NCBI
|
|
11
|
Sato M, Nakai Y, Nakata W, Yoshida T,
Hatano K, Kawashima A, Fujita K, Uemura M, Takayama H and Nonomura
N: EMMPRIN promotes angiogenesis, proliferation, invasion and
resistance to sunitinib in renal cell carcinoma, and its level
predicts patient outcome. PLoS One. 8:e743132013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Omi Y, Shibata N, Okamoto T, Obara T and
Kobayashi M: The role of CD147 in the invasiveness of follicular
thyroid carcinoma cells. Thyroid. 22:383–394. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Stenzinger A, Wittschieber D, von
Winterfeld M, Goeppert B, Kamphues C, Weichert W, Dietel M, Rabien
A and Klauschen F: High extracellular matrix metalloproteinase
inducer/CD147 expression is strongly and independently associated
with poor prognosis in colorectal cancer. Hum Pathol. 43:1471–1481.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhu S, Chu D, Zhang Y, Wang X, Gong L, Han
X, Yao L, Lan M, Li Y and Zhang W: EMMPRIN/CD147 expression is
associated with disease-free survival of patients with colorectal
cancer. Med Oncol. 30:3692013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zheng HC, Wang W, Xu XY, Xia P, Yu M,
Sugiyama T and Takano Y: Up-regulated EMMPRIN/CD147 protein
expression might play a role in colorectal carcinogenesis and its
subsequent progression without an alteration of its glycosylation
and mRNA level. J Cancer Res Clin Oncol. 137:585–596. 2011.
View Article : Google Scholar
|
|
16
|
Toole BP and Slomiany MG: Hyaluronan, CD44
and Emmprin: Partners in cancer cell chemoresistance. Drug Resist
Updat. 11:110–121. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Falls JG, Pulford DJ, Wylie AA and Jirtle
RL: Genomic imprinting: Implications for human disease. Am J
Pathol. 154:635–647. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Engel N, Thorvaldsen JL and Bartolomei MS:
CTCF binding sites promote transcription initiation and prevent DNA
methylation on the maternal allele at the imprinted H19/Igf2 locus.
Hum Mol Genet. 15:2945–2954. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lambert S, Vivario J, Boniver J and
Gol-Winkler R: Abnormal expression and structural modification of
the insulin-like growth-factor-II gene in human colorectal tumors.
Int J Cancer. 46:405–410. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cui H, Cruz-Correa M, Giardiello FM,
Hutcheon DF, Kafonek DR, Brandenburg S, Wu Y, He X, Powe NR and
Feinberg AP: Loss of IGF2 imprinting: A potential marker of
colorectal cancer risk. Science. 299:1753–1755. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pan Y, He B, Li T, Zhu C, Zhang L, Wang B,
Xu Y, Qu L, Hoffman AR, Wang S, et al: Targeted tumor gene therapy
based on loss of IGF2 imprinting. Cancer Biol Ther. 10:290–298.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nie ZL, Pan YQ, He BS, Gu L, Chen LP, Li
R, Xu YQ, Gao TY, Song GQ, Hoffman AR, et al: Gene therapy for
colorectal cancer by an oncolytic adenovirus that targets loss of
the insulin-like growth factor 2 imprinting system. Mol Cancer.
11:862012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sun H, Pan Y, He B, Deng Q, Li R, Xu Y,
Chen J, Gao T, Ying H, Wang F, et al: Gene therapy for human
colorectal cancer cell lines with recombinant adenovirus 5 based on
loss of the insulin-like growth factor 2 imprinting. Int J Oncol.
46:1759–1767. 2015.PubMed/NCBI
|
|
24
|
Yan L, Zucker S and Toole BP: Roles of the
multifunctional glycoprotein, emmprin (basigin; CD147), in tumour
progression. Thromb Haemost. 93:199–204. 2005.PubMed/NCBI
|
|
25
|
Lynch CC and Matrisian LM: Matrix
metalloproteinases in tumor-host cell communication.
Differentiation. 70:561–573. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kanekura T, Chen X and Kanzaki T: Basigin
(CD147) is expressed on melanoma cells and induces tumor cell
invasion by stimulating production of matrix metalloproteinases by
fibroblasts. Int J Cancer. 99:520–528. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Abraham D, Zins K, Sioud M, Lucas T and
Aharinejad S: Host CD147 blockade by small interfering RNAs
suppresses growth of human colon cancer xenografts. Front Biosci.
13:5571–5579. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xu T, Zhou M, Peng L, Kong S, Miao R, Shi
Y, Sheng H and Li L: Upregulation of CD147 promotes cell invasion,
epithelial-to-mesenchymal transition and activates MAPK/ERK
signaling pathway in colorectal cancer. Int J Clin Exp Pathol.
7:7432–7441. 2014.
|
|
29
|
Yang Y, Hu JF, Ulaner GA, Li T, Yao X, Vu
TH and Hoffman AR: Epigenetic regulation of Igf2/H19 imprinting at
CTCF insulator binding sites. J Cell Biochem. 90:1038–1055. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Paradowska A, Fenic I, Konrad L, Sturm K,
Wagenlehner F, Weidner W and Steger K: Aberrant epigenetic
modifications in the CTCF binding domain of the IGF2/H19 gene in
prostate cancer compared with benign prostate hyperplasia. Int J
Oncol. 35:87–96. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ito Y, Koessler T, Ibrahim AE, Rai S,
Vowler SL, Abu-Amero S, Silva AL, Maia AT, Huddleston JE,
Uribe-Lewis S, et al: Somatically acquired hypomethylation of IGF2
in breast and colorectal cancer. Hum Mol Genet. 17:2633–2643. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kaneda A and Feinberg AP: Loss of
imprinting of IGF2: A common epigenetic modifier of intestinal
tumor risk. Cancer Res. 65:11236–11240. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yang JM, Xu Z, Wu H, Zhu H, Wu X and Hait
WN: Overexpression of extracellular matrix metalloproteinase
inducer in multidrug resistant cancer cells. Mol Cancer Res.
1:420–427. 2003.PubMed/NCBI
|
|
34
|
Zou W, Yang H, Hou X, Zhang W, Chen B and
Xin X: Inhibition of CD147 gene expression via RNA interference
reduces tumor cell invasion, tumorigenicity and increases
chemosensitivity to paclitaxel in HO-8910pm cells. Cancer Lett.
248:211–218. 2007. View Article : Google Scholar
|
|
35
|
Jia L, Wang H, Qu S, Miao X and Zhang J:
CD147 regulates vascular endothelial growth factor-A expression,
tumorigenicity, and chemosensitivity to curcumin in hepatocellular
carcinoma. IUBMB Life. 60:57–63. 2008. View
Article : Google Scholar : PubMed/NCBI
|
